Stimulation and Medication Effects on Subthalamic Nucleus Beta‐Band Power in Parkinson's Disease: Implications for Adaptive Deep Brain Stimulation
The spectral characteristics of STN beta oscillations and their performance as a biomarker in aDBS for Parkinson's disease are influenced by the stimulation and medication conditions in which it is implemented. © 2026 International Parkinson and Movement Disorder Society.
Authors
- Carina R. Oehrn (ORCID: https://orcid.org/0000-0001-8451-7960)
- Stephanie Cernera (ORCID: https://orcid.org/0000-0002-6885-6791)
- Jiaang Yao (ORCID: https://orcid.org/0000-0001-7062-2508)
- Maria Shcherbakova
- Philip Starr
- Simon Little
- Lauren H. Hammer
- Amelia G. Hahn
Institutions
- University of California, San Francisco (US)
- Loyola University Chicago (US)
- Neurological Surgery (US)
- University of Pennsylvania (US)
- University of California, Davis (US)
Publication Details
- Journal
- Movement Disorders
- Published
- 2026-03-11
- DOI
- https://doi.org/10.1002/mds.70261
- Primary Topic
- Neurological disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00